The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes

Endocrinology. 1996 Sep;137(9):4054-7. doi: 10.1210/endo.137.9.8756584.


Various model systems have been used to study the expression of the recently cloned ob gene, leptin. Here we report that freshly isolated rat white adipocytes incubated with insulin release leptin in a rapid and concentration-dependent manner (EC50 of 0.221 +/- .075 nM). Insulin-stimulated leptin release could be detected as early as 30 min and a maximal 2-3 fold effect was produced by 10 nM insulin. The effect of insulin was completely blocked by simultaneous activation of cAMP-dependent protein kinase. Using the activation of lipolysis as an index of cAMP-dependent protein kinase activity, we show that inhibition of leptin release by norepinephrine or the selective beta 3-adrenergic receptor agonist, CL316,243, occurred in parallel to activation of cAMP-dependent protein kinase. In addition, beta 1- and beta 2-adrenergic receptor antagonists did not impair the ability of norepinephrine or CL316,243 to inhibit leptin release from the adipocytes. These findings suggest that the beta 3-adrenergic receptor plays a central role in regulating the release of leptin from the adipocyte.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adipocytes / metabolism*
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Cell Separation
  • Cyclic AMP-Dependent Protein Kinases / pharmacology
  • Enzyme Activation
  • Insulin / pharmacology*
  • Insulin Antagonists / pharmacology
  • Leptin
  • Male
  • Obesity / genetics
  • Proteins / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, beta / physiology*


  • Adrenergic beta-Agonists
  • Insulin
  • Insulin Antagonists
  • Leptin
  • Proteins
  • Receptors, Adrenergic, beta
  • Cyclic AMP-Dependent Protein Kinases